CN Stock MarketDetailed Quotes

300759 Pharmaron Beijing

Watchlist
  • 28.79
  • -0.38-1.30%
Market Closed Nov 1 15:00 CST
51.46BMarket Cap27.31P/E (TTM)

About Pharmaron Beijing Company

The company is an internationally leading life science research and development service enterprise. Since its establishment in 2004, Kanglong Chemical has been committed to its talent training and facility construction, and has built an R&D and production service system throughout the entire process of drug discovery, pre-clinical and clinical development for multi-therapy drug research and development, including small molecules, macromolecules, and cell and gene therapy drugs. The company is a leading full-process integrated pharmaceutical research and development service platform. It operates all over the world and is committed to helping customers accelerate drug innovation. Products include small molecule chemicals, large molecule biopharmaceuticals, cell and gene therapy products, etc.

Company Profile

Short Name-A康龙化成
Symbol-A300759
Short Name-H康龙化成
Symbol-H03759
Company NamePharmaron Beijing Co., Ltd.
Listing DateJan 28, 2019
Issue Price7.66
Shares Offered65.63M share(s)
FoundedJul 1, 2004
Legal RepresentativeBoliang Lou
General Managerxiaoqiang lou
Secretarychengzong li
Accounting FirmErnst & Young (Special General Partnership)
Legal CounselBeijing Zhong Lun Law Firm
Employees20342
Phone010-57330087
Office AddressNo. 6 Taihe Road, Beijing Economic and Technological Development Zone, Beijing
Zip Code100176
Registered Address8th Floor, Building 1, No. 6 Taihe Road, Beijing Economic and Technological Development Zone, Beijing
Fax010-57330087
Emailpharmaron@pharmaron.com
Websitehttp://www.pharmaron.cn/
Business License110000410205747
BusinessResearch and development of medicinal compounds, chemicals, biological products, and biotechnology; provision of technical development, technology transfer, technical consulting, technical services, technical training; import and export of goods and technology. (For projects subject to approval according to law, business activities are carried out according to the approved content after approval by the relevant departments.) (Subject to the scope of business approved by the market supervisory and regulatory authority)

Company Executives

  • Name
  • Position
  • Salary
  • Boliang Lou
  • Chairman, Executive Director, CEOs, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
  • 2.21M
  • jiaqing li
  • Non-executive Directors, Member of the Strategy Committee
  • --
  • xiaoqiang lou
  • Executive Director, President, Member of the Strategy Committee, Chief Operating Officer, Member of the Remuneration and Assessment Committee
  • 1.91M
  • baifeng hu
  • Non-executive Directors, Member of the Strategy Committee
  • --
  • bei zheng
  • Executive Director, Executive Vice President (Deputy Manager), Nomination Committee Members
  • 1.60M
  • kunhongxiansheng ceng
  • Independent Non-Executive Director, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Audit Committee Member
  • 220.00K
  • jian yu
  • Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Member of the Remuneration and Assessment Committee
  • 300.00K
  • qilin zhou
  • Independent Non-Executive Director, Member of the Strategy Committee
  • 300.00K
  • lihua li
  • Independent Non-Executive Director, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
  • 300.00K
  • Gilbert Shing Chung Li
  • Board Secretary, Chief Financial Officer (Head of Finance)
  • 6.89M
  • Kexin Yang
  • Chairman of the Supervisory Board, Auditors
  • 1.54M
  • shu feng
  • Auditors
  • --
  • Hua Yang
  • Chief Scientific Officer (Deputy Manager), Core technical personnel
  • 1.80M
  • lan zhang
  • Employee Supervisors
  • 829.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data